LinkinLegal
Craig Titmus photo

Craig Titmus

Craig’s practice covers diverse biotechnological subject matter, with a particular focus on vaccines, diagnostics, gene therapy, therapeutic antibodies and peptides, and biofuels. Craig has significant experience of European and international patent prosecution, and coordinates global IP strategies for a range of clients including startups, SMEs, universities, large corporations and the UK Government. · Mathys & Squire LLP

EnglandIntellectual Property, Patent Prosecution
EmailCall

About

Craig advises on a broad range of biotechnological subject matter with particular focus on vaccines, diagnostics, gene therapy, therapeutic antibodies and peptides, and biofuels. He has significant experience in European and international patent prosecution and coordinates global IP strategies for clients including startups, SMEs, universities, large corporations and the UK Government.

Practice areas

Intellectual PropertyPatent ProsecutionLife Sciences / BiotechnologyVaccinesDiagnosticsGene TherapyTherapeutic Antibodies & PeptidesBiofuels

Office

England

Mathys & Squire LLP · Craig’s practice covers diverse biotechnological subject matter, with a particular focus on vaccines, diagnostics, gene therapy, therapeutic antibodies and peptides, and biofuels. Craig has significant experience of European and international patent prosecution, and coordinates global IP strategies for a range of clients including startups, SMEs, universities, large corporations and the UK Government.

England

Expertise

VaccinesDiagnosticsGene TherapyTherapeutic AntibodiesPeptidesBiofuelsEuropean and International Patent ProsecutionGlobal IP Strategy for startups, SMEs, universities, corporates and government

Education

  • BSc (First Class) in Molecular Biology and Biochemistry, University of Durham (ranked top in his year)
  • PhD, University of Cambridge (collaboration with a multinational crop research company) — focus on environmental stress tolerance in plants and interfaces between metabolism and the cell cycle

Admissions

  • Chartered Institute of Patent Attorneys (CIPA) - Member
  • European Patent Institute (EPI) - Member
  • One Nucleus IP Mentor - Appointed